 |
|
Spermicides, HIV, and the Vaginal Sponge
Katherine M. Stone, MD;
Herbert B. Peterson, MD
JAMA. 1992;268(4):521-523.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Despite the current epidemic of sexually transmitted human immunodeficiency virus (HIV) infection and other sexually transmitted diseases (STDs), prevention measures known to be effective are underutilized. Most prevention guidelines have appropriately emphasized abstinence, monogamy between uninfected partners, or condom use. Condoms are highly effective if used consistently and correctly.1 These strategies, however, are not acceptable to some persons at high risk for HIV infection. Furthermore, women at risk for HIV infection must depend on male partners to use condoms. In recent years, the desire to protect women from HIV infection and the sense of desperate need for strategies less dependent on male cooperation have ignited sparks of enthusiasm for vaginal spermicides as a preventive measure. Data to support use of vaginal spermicides, including the nonoxynol 9 sponge, to prevent HIV infection include (1) laboratory studies that showed that nonoxynol 9 and other spermicides inactivate HIV
See also p 477.
. . . [Full Text PDF of this Article]
Author Affiliations
From the Division of STD/HIV Prevention, National Center for Prevention Services (Dr Stone), and the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion (Dr Peterson), Centers for Disease Control, Atlanta, Ga.
Footnotes
Reprint requests to Information Services, National Center for Prevention Services, Centers for Disease Control, Mail Stop E06, Atlanta, GA 30333 (Dr Stone).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
